Browse Content

Page 3 of 134
Sort by:
You must be signed in to view content.

Rationale for Targeting Eosinophils in Achalasia, Eosinophilic Gastrointestinal Disease, and Functional Gastrointestinal Disorders

Content Type: Presentations

Objective: Appreciate the rationale for growing interest in novel therapies targeting eosinophils in the management of achalasia, eosinophilic gastrointestinal disease, and functional GI disorders.

Presenter: Nirmala P Gonsalves MD

Release Date: 6/15/2022

Event: 2021 GI Pathophysiology Course

CME Value: 0 minutes

Gastrointestinal and Hepatic Implications of COVID-19

Content Type: Presentations

Objective: Understand the clinical implications of gastrointestinal and hepatic manifestations of SARS-CoV-2.

Presenter: Luis F Lara MD

Release Date: 6/15/2022

Event: 2021 GI Pathophysiology Course

CME Value: 0 minutes

Proton Pump Inhibitor Adverse Effects: Fact or Fiction?

Content Type: Presentations

Objective: Describe the scientific rationale and evidence for adverse effects of proton pump inhibitor therapy.

Presenter: Paul Moayyedi MB ChB, PhD, MPH, FACG

Release Date: 6/15/2022

Event: 2021 GI Pathophysiology Course

CME Value: 0 minutes

Celiac Disease: From Disease Understanding to Management Strategies

Content Type: Presentations

Objective: Detail the mechanisms of disease and both diagnostic and management strategies for patients with celiac disease.

Presenter: Amy S Oxentenko MD, FACG

Release Date: 6/15/2022

Event: 2021 GI Pathophysiology Course

CME Value: 0 minutes

Pathophysiology Basis for Current and Future Management of Acute Pancreatitis

Content Type: Presentations

Objective: Identify the scientific basis for novel therapeutic approaches to pancreatitis.

Presenter: Georgios I. Papachristou MD, PhD, FACG

Release Date: 6/15/2022

Event: 2021 GI Pathophysiology Course

CME Value: 0 minutes

Scientific Foundations of Novel Immunologic Approaches to IBD

Content Type: Presentations

Objective: Apply concepts regarding the immunologic basis of novel biologic therapies to the management of IBD.

Presenter: Miguel D Regueiro MD, FACG

Release Date: 6/15/2022

Event: 2021 GI Pathophysiology Course

CME Value: 0 minutes

Application of Molecular and Genetic Testing to the Management of Colon Polyps and Cancer

Content Type: Presentations

Objective: Formulate a clinical approach to the use of molecular and genetic testing in the evaluation and management of colon polyps and cancer.

Presenter: Elena M Stoffel MD, MPH

Release Date: 6/15/2022

Event: 2021 GI Pathophysiology Course

CME Value: 0 minutes

Update on Treating C. difficile Infection

Content Type: Presentations

Objective: Apply principles of recent guideline updates in the management of patients with C. difficile in a variety of clinical scenarios.

Presenter: Jessica R Allegretti MD, MPH, FACG

Release Date: 6/15/2022

Event: 2021 Pharmacology Course

CME Value: 0 minutes

Understanding the Different Treatment Options for Hepatitis C

Content Type: Presentations

Objective: Differentiate among HCV therapies and identify optimal care plans based on specific clinical situations.

Presenter: Kimberly A. Brown MD

Release Date: 6/15/2022

Event: 2021 Pharmacology Course

CME Value: 0 minutes

ACG Clinical Practice Guideline on Pharmacotherapy for IBS

Content Type: Presentations

Objective: Develop evidence-based approaches to the evaluation and pharmacologic treatment of patients with irritable bowel syndrome based on critical review of recent guideline updates.

Presenter: Brooks D Cash MD, FACG

Release Date: 6/15/2022

Event: 2021 Pharmacology Course

CME Value: 0 minutes